NAVA.OL - Navamedic ASA

Oslo - Oslo Delayed Price. Currency in NOK
10.00
+0.17 (+1.73%)
At close: 4:25PM CET
Stock chart is not supported by your current browser
Previous Close9.83
Open9.99
Bid9.90 x 96200
Ask10.10 x 491200
Day's Range9.99 - 10.20
52 Week Range8.50 - 14.50
Volume6,162
Avg. Volume10,375
Market Cap108.68M
BetaN/A
PE Ratio (TTM)24.94
EPS (TTM)0.40
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
  • GlobeNewswire8 days ago

    Navamedic ASA: Q3 2017 results

      Oslo, November 10, 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 44.9 million in the third quarter of 2017, down from NOK 65.2 million in the same period in 2016, following the planned discontinuation ...

  • GlobeNewswire3 months ago

    Navamedic ASA: Trade by primary insider

    Kathryn Baker, Chairman of the Board in Navamedic ASA has of 24 August 2017 acquired 3400 shares in Navamedic ASA. The shares are acquired through her company Lakeside AS at an average price of NOK 10,80 ...

  • GlobeNewswire3 months ago

    Navamedic ASA: Enters into partnership agreement for distribution of ELMIRON® in the Nordics

    Oslo, August 21, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arznemittel GmbH (bene) ...

  • GlobeNewswire4 months ago

    Navamedic ASA: Second quarter results 2017

    Oslo, 28 July 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 89.7 million in the second quarter of 2017 (NOK 66.7 million in Q2 2016), representing a growth of 34.4%, following the successful ...

  • GlobeNewswire4 months ago

    Navamedic ASA: Presentation of second quarter figures

    Navamedic ASA invites you to follow an online presentation of the second quarter 2017 figures. The presentation will be webcasted at www.navamedic.com - investor relations - presentations - webcast on ...

  • GlobeNewswire5 months ago

    Annual General Meeting held

    Navamedic ASA has today, 6 June 2017, held an annual general meeting. All resolutions were made in accordance with the board`s/nomination committee`s proposals. The minutes from the general meeting is ...

  • GlobeNewswire6 months ago

    Navamedic ASA: Granted European patent for Sippi® base technology

    Oslo, May 31, 2017 - Navamedic ASA (OSE: NAVA) announced today that it has been granted a patent by the European Patent Office for the base technology of Sippi®, using capacitance as a volume measurement ...

  • GlobeNewswire6 months ago

    Navamedic ASA: Notice of Annual General Meeting

    The Annual General Meeting in Navamedic ASA will take place on Tuesday 6 June 2017 at 13.00 at Hotel Continental, Stortingsgaten 24-26, Oslo. Please find attached the annual report. Notice of the meeting, ...

  • GlobeNewswire6 months ago

    Navamedic ASA: Q1 2017 results

    Oslo, 10 May 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 78.2 million in the first quarter of 2017 (NOK 60.8 million in Q1 2016), representing a growth of 28.6%, in part due to a widened ...

  • GlobeNewswire6 months ago

    Navamedic ASA: Invitation to presentation of first quarter results 2017

    Navamedic ASA invites you to a presentation of the first quarter 2017 figures. The presentation takes place at Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Wednesday 10 May. The presentation will ...

  • GlobeNewswire7 months ago

    Navamedic ASA: Enters into partnership agreement with Orexigen Therapeutics for Nordic launch of Mysimba®

    Oslo, May 2, 2017 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a five-year agreement with Orexigen Therapeutics Ireland, Ltd., ...

  • PR Newswire7 months ago

    Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries

    SAN DIEGO, May 2, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (OREX) today announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Navamedic AB, an affiliate of Navamedic ASA (NAVA.OL), have executed a distributorship agreement covering Denmark, Finland, Iceland, Norway and Sweden for Mysimba® (naltrexone HCl / bupropion HCl prolonged release).  Navamedic ASA manufactures and markets pharmaceutical products and medical technology to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets.

  • GlobeNewswire7 months ago

    Navamedic ASA: Annual Report 2016

        Attached: The Annual Report 2016 for Navamedic ASA. The report will also be avaiable on Navamedic`s website: www.navamedic.com       For further information please contact:   CFO Toril Ås E-mail:toril.as@navamedic.com ...

  • GlobeNewswire9 months ago

    Navamedic ASA: Q4 2016 results

    Oslo, 15 February 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 81.6 million in the fourth quarter of 2016 (NOK 65.4 million in Q4 2015), and an EBITDA of NOK 5.7 million (NOK -0.1 million ...

  • GlobeNewswire9 months ago

    Navamedic ASA: Invitation to presentation of fourth quarter results 2016

    Navamedic ASA will present its fourth quarter 2016 report in an extended event on Wednesday, February 15 2017 at Hotel Continental in Oslo, Norway. Navamedic is proud to announce Prof. Jan Van Der Linden ...

  • GlobeNewswire10 months ago

    Navamedic ASA: Save the date - Extended fourth quarter presentation

    Navamedic ASA will present its fourth quarter 2016 report in an extended event on Wednesday, February 15 2017 at Hotel Continental in Oslo, Norway. Navamedic is proud to announce Prof. Jan Van Der Linden ...

  • GlobeNewswire10 months ago

    Navamedic ASA: Sippcoat granted European patent

    Oslo, 20 January 2017 - Navamedic ASA today announced that the European Patent Office has granted a patent for Sippcoat® to be used in any urine handling system to help prevent bacteria migration. This ...

  • GlobeNewswire10 months ago

    Navamedic: New Chairman and member of the Board of Directors

    Oslo, 16. January 2017 - The Extraordinary General Meeting of Navamedic ASA (OSE: NAVA) has elected Kathryn M. Baker as Chairman of the Board of Directors and Jostein Davidsen as a new board member. "It ...

  • GlobeNewswire10 months ago

    Navamedic ASA : Extra ordinary general meeting held

    Navamedic ASA has today,13 January 2017, held an extra ordinary general meeting. All resolutions were made in accordance with the board`s/nomination committee`s proposals.   The minutes from the general ...